Study finds pregnancy risks higher with ART in kidney transplant recipients
UC physician-scientist's work featured in Contemporary OB/GYN
The odds of complications during pregnancy may be increased among women with kidney transplants conceiving through assisted reproductive technology (ART), according to a new study led by the University of Cincinnati's Silvi Shah, MD, and published in Transplantation. It was recently featured in Contemporary OB/GYN.
It's among the first large-scale research assessing pregnancy outcomes in women with kidney transplants. Alongside increased hypertension risk, this population presented with increased risks of cesarean delivery, preterm birth and reduced infant birth weight.
“Until now, little has been known about the outcomes of pregnancies using assisted reproductive technology in women with kidney transplants,” said Shah, associate professor of nephrology in the College of Medicine. “Our study provides valuable evidence to guide physicians when counseling patients toward family-planning decision-making and the use of assisted reproductive technology."
These results highlighted increased risks of certain pregnancy complications among kidney transplant recipients utilizing ART. However, as other risks such as live birth rates and two-year kidney transplant survival did not increase, investigators concluded ART remains safe for use in patients who received a kidney transplant.
Women with chronic kidney disease often experience significant adverse impacts on fertility. A large proportion of this population may be able to conceive naturally following kidney transplantation, but some may continue to experience infertility, requiring the use of ART to conceive.
Shah noted that this data now allows for a greater understanding of how clinicians can optimize care for kidney transplant recipients planning to conceive with ART. Additionally, clinicians may use this information to help patients make informed reproductive choices.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.